Valsartan drugs recall in Canada: potential cancer risk
In plain language
This recall involves several drugs containing valsartan sold in Canada. They are being recalled because an impurity, N-nitrosodimethylamine (NDMA), a potential carcinogen, was found in the valsartan ingredient. If you are taking any medication containing valsartan, speak to your pharmacist to see if your medicine is being recalled. If you have an affected product, contact your healthcare practitioner to discuss treatment options.
What to do
- Keep taking your medicine unless told to stop by your doctor or pharmacist.
- Speak to your pharmacist to check if your medicine is recalled.
- Contact your healthcare practitioner if you have an affected product.
- Report side effects to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
Potential cancer risk from impurity
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Potential cancer risk from impurity
What should consumers do?
Keep taking your medicine unless told to stop by your doctor or pharmacist. Speak to your pharmacist to check if your medicine is recalled. Contact your healthcare practitioner if you have an affected product. Report side effects to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Potential cancer risk from impurity
When was this product recalled?
This product was recalled on July 9, 2018.